Liver transplantation for hepatocellular carcinoma: Role of biopsy
✍ Scribed by François Durand; Jacques Belghiti; Valérie Paradis
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 126 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21326
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Liver transplantation for unresectable hepatocellular carcinoma yields disappointing results. Most cases recur within 2 years, often in the transplanted liver. Methods: A combination of neoadjuvant doxorubicin and orthotopic liver transplantation was used in 20 patients with unresectable
## Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendotheli